Abbott Laboratories (ABT) advanced in recent intraday trading, with the stock remaining within a short-term bullish corrective trend. Positive momentum continues to be supported by the stock's trading above its 50-day Simple Moving Average (SMA), which is acting as dynamic support and strengthening the prospects for extending the recent gains in the near term. Meanwhile, momentum indicators have begun generating fresh bullish signals after previously reaching oversold territory, further reinforcing the positive technical outlook.

Therefore, our outlook remains bullish for the stock's upcoming trading sessions, as long as support at $102.90 remains intact. Under this scenario, the stock is expected to target its first resistance level at $114.00.

Today's price forecast: Bullish.